Captrust Financial Advisors
- SEC CIK
- 0001512024
- Latest filing
- Aug 13, 2026
CLSD holding history
Clearside Biomedical, Inc. in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLSD overviewAll 13F holders of CLSDFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −5,800−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q2 2025 | 87,000 | $69.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 87,000 | $79.9K | <0.1% | −14,208−14.0% | Reduced | Holders |
| Q4 2024 | 101,208 | $96.1K | <0.1% | +8,473+9.1% | Added | Holders |
| Q3 2024 | 92,735 | $117.8K | <0.1% | +5,735+6.6% | Added | Holders |
| Q2 2024 | 87,000 | $113.1K | <0.1% | +37,000+74.0% | Added | Holders |
| Q1 2024 | 50,000 | $76.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 50,000 | $58.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 50,000 | $43.5K | <0.1% | +25,914+107.6% | Added | Holders |
| Q2 2023 | 24,086 | $27.0K | <0.1% | +3,080+14.7% | Added | Holders |
| Q1 2023 | 21,006 | $21.8K | <0.1% | +21,006 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −4,400−100.0% | Sold out | Holders |
| Q2 2022 | 4,400 | $6.00K | <0.1% | +4,300+4,300.0% | Added | Holders |
| Q1 2022 | 100 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q4 2021 | 100 | $0 | 0.0% | +100 | New | Holders |